Quanterix Corporation Cash and Cash Equivalents, Fair Value Disclosure
Quanterix Corporation (QTRX) had Cash and Cash Equivalents, Fair Value Disclosure of $24.56 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Fair Value Disclosures
us-gaap:CashAndCashEquivalentsFairValueDisclosure · last filed 2026-08-10
- 2026-06-30: Cash and Cash Equivalents, Fair Value Disclosure $24.56M.
- 2026-03-31: Cash and Cash Equivalents, Fair Value Disclosure $22.48M.
- 2025-12-31: Cash and Cash Equivalents, Fair Value Disclosure $17.22M.
- 2025-09-30: Cash and Cash Equivalents, Fair Value Disclosure $23.85M.
| Period end | Cash and Cash Equivalents, Fair Value Disclosure | Cash and Cash Equivalents, Fair Value Disclosure as first filed |
|---|---|---|
| 2026-06-30 | $24.56M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $22.48M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $17.22M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $23.85M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $1.65M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $57.38M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $44.43M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $13.02M 10-Q · filed 2024-12-26 | |
| 2024-06-30 | $31.76M 10-Q/A · filed 2024-12-26 | |
| 2024-03-31 | $36.25M 10-Q/A · filed 2024-12-26 | |
| 2023-12-31 | $162.26M 10-K · filed 2025-03-17 | |
| 2023-09-30 | $178.58M 10-Q · filed 2023-11-08 | |
| 2022-12-31 | $306.10M 10-K · filed 2023-03-06 | |
| 2021-12-31 | $332.09M 10-K · filed 2023-03-06 | |
| 2021-09-30 | $162.08M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $162.07M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $162.06M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $162.05M 10-K · filed 2022-03-01 | $162.05M 10-K · filed 2021-03-05 |
| 2020-09-30 | $162.04M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $82.01M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $91.92M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $102.75M 10-K · filed 2021-03-05 | $109.16M 10-K · filed 2020-03-13 |
| 2019-09-30 | $101.25M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $43.27M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $31.96M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $42.61M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $49.31M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $57.46M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $64.01M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $78.18M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |